Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Peer

Cancer letters

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Letters|April 1, 2014
Featuring the special issue guest editor: Dan Peer, Ph.DDan Peer
Cancer Letters|April 29, 2014
Precision medicine--delivering the goods?Dan Peer
Cancer Letters|August 15, 2013
Omics-based nanomedicine: the future of personalized oncologyDaniel Rosenblum, Dan Peer
Cancer Letters|July 15, 2005
Fluoxetine and reversal of multidrug resistanceDan Peer, Rimona Margalit
Cancer Letters|September 1, 2014
Modulating cancer multidrug resistance by sertraline in combination with a nanomedicineVelthe Drinberg, Rivka Bitcover, Wolf Rajchenbach, et al.
Cancer Letters|October 15, 2008
Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimenMirit Argov, Rina Kashi, Dan Peer, et al.
Cancer Letters|April 30, 2013
eIF3c: a potential therapeutic target for cancerRafi Emmanuel, Shiri Weinstein, Dalit Landesman-Milo, et al.
Cancer Letters|May 3, 2015
Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytesInbal Hazan-Halevy, Daniel Rosenblum, Shiri Weinstein, et al.
Cancer Letters|May 16, 2015
Serum chemokine network correlates with chemotherapy in non-small cell lung cancerDawei Yang, Jian Zhou, Tao Zeng, et al.
Cancer Letters|September 1, 2012
Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cellsDalit Landesman-Milo, Meir Goldsmith, Shani Leviatan Ben-Arye, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Letters|April 1, 2014
Featuring the special issue guest editor: Dan Peer, Ph.DDan Peer
Cancer Letters|April 29, 2014
Precision medicine--delivering the goods?Dan Peer
Cancer Letters|August 15, 2013
Omics-based nanomedicine: the future of personalized oncologyDaniel Rosenblum, Dan Peer
Cancer Letters|July 15, 2005
Fluoxetine and reversal of multidrug resistanceDan Peer, Rimona Margalit
Cancer Letters|September 1, 2014
Modulating cancer multidrug resistance by sertraline in combination with a nanomedicineVelthe Drinberg, Rivka Bitcover, Wolf Rajchenbach, et al.
Cancer Letters|October 15, 2008
Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimenMirit Argov, Rina Kashi, Dan Peer, et al.
Cancer Letters|April 30, 2013
eIF3c: a potential therapeutic target for cancerRafi Emmanuel, Shiri Weinstein, Dalit Landesman-Milo, et al.
Cancer Letters|May 3, 2015
Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytesInbal Hazan-Halevy, Daniel Rosenblum, Shiri Weinstein, et al.
Cancer Letters|May 16, 2015
Serum chemokine network correlates with chemotherapy in non-small cell lung cancerDawei Yang, Jian Zhou, Tao Zeng, et al.
Cancer Letters|September 1, 2012
Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cellsDalit Landesman-Milo, Meir Goldsmith, Shani Leviatan Ben-Arye, et al.
Pageof 1